MXCT - MaxCyte - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

MXCT is currently covered by 4 analysts with an average price target of $10.74. This is a potential upside of $7 (187.17%) from yesterday's end of day stock price of $3.74.

MaxCyte's activity chart (see below) currently has 5 price targets and 17 ratings on display. The stock rating distribution of MXCT is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for MXCT is $12, Lowest price target is $8, average price target is $10.74.

Most recent stock forecast was given by MARK MASSARO from BTIG on 13-Mar-2024. First documented stock forecast 24-Aug-2021.

Best performing analysts who are covering MXCT - MaxCyte:

Mark Massaro Jeff Johnson Daniel Arias

Currently out of the existing stock ratings of MXCT, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$4.26 (113.90%)

7

1 months 13 days ago

0/6 (0%)

$3.84 (92.31%)

Buy

11

$7.26 (194.12%)

18

5 months 17 days ago

0/2 (0%)

$7.76 (239.51%)

Buy

12

$7.98 (198.51%)

12

6 months 21 days ago

0/4 (0%)

$9.4 (361.54%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MXCT (MaxCyte) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MXCT (MaxCyte) with a proven track record?

MARK MASSARO

Which analyst has the current lower performing score on MXCT (MaxCyte) with a proven track record?

DANIEL ARIAS

Which analyst has the most public recommendations on MXCT (MaxCyte)?

Mark Massaro works at BTIG and has 6 price targets and 3 ratings on MXCT

Which analyst is the currently most bullish on MXCT (MaxCyte)?

Jeff Johnson with highest potential upside - $7.98

Which analyst is the currently most reserved on MXCT (MaxCyte)?

Mark Massaro with lowest potential downside - $4.26

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?